Occudo Quantitative Strategies LP Fulcrum Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $283,959 - $531,221	87,372 New	87,372 $387,000
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $37,443 - $185,101	13,231 Added 50.87%	39,239 $111,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $33,246 - $55,410	-6,636 Reduced 20.33%	26,008 $189,000
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $5,933 - $10,974	1,206 Added 3.84%	32,644 $264,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $132,039 - $754,512	31,438 New	31,438 $154,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.